BFA
MDCO

BlackRock Fund Advisors’s Medicines Co MDCO Stock Holding History

BlackRock Fund Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$232M Buy
6,830,448
+775,226
+13% +$27.5M 0.04% 535
2016
Q3 		$229M Buy
6,055,222
+438,872
+8% +$16.5M 0.05% 470
2016
Q2 		$189M Buy
5,616,350
+138,576
+3% +$4.89M 0.04% 523
2016
Q1 		$174M Buy
5,477,774
+80,649
+1% +$2.63M 0.04% 557
2015
Q4 		$202M Buy
5,397,125
+178,192
+3% +$6.73M 0.05% 481
2015
Q3 		$198M Sell
5,218,933
-5,479
-0.1% -$192K 0.05% 431
2015
Q2 		$149M Buy
5,224,412
+6,358
+0.1% +$177K 0.04% 670
2015
Q1 		$146M Buy
5,218,054
+336,733
+7% +$9.46M 0.03% 695
2014
Q4 		$135M Buy
4,881,321
+438,775
+10% +$10.9M 0.03% 705
2014
Q3 		$99.2M Buy
4,442,546
+23,454
+0.5% +$596K 0.03% 838
2014
Q2 		$128M Sell
4,419,092
-11,919
-0.3% -$318K 0.04% 686
2014
Q1 		$126M Buy
4,431,011
+30,555
+0.7% +$1.01M 0.04% 673
2013
Q4 		$170M Buy
4,400,456
+197,009
+5% +$7.04M 0.05% 454
2013
Q3 		$141M Buy
4,203,447
+845,205
+25% +$26.9M 0.05% 507
2013
Q2 		$103M Buy
+3,358,242
New +$112M 0.04% 640

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BlackRock Fund Advisors's MDCO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Medicines Co (MDCO) stake by 13% in Q4 2016, buying an estimated $27.5M and bringing the position to 6,830,448 shares worth $232M. The position accounts for 0.04% of the portfolio, ranked #535.

BlackRock Fund Advisors first reported a position in MDCO in Q2 2013 and has held it in 15 quarters since. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • BlackRock Fund Advisors held 6,830,448 shares of Medicines Co worth $232M as of Q4 2016.
  • BlackRock Fund Advisors bought 775,226 Medicines Co shares in Q4 2016, an estimated $27.5M.
  • Medicines Co made up 0.04% of BlackRock Fund Advisors's portfolio in Q4 2016, its #535 holding.
  • BlackRock Fund Advisors first reported a position in Medicines Co in Q2 2013 and has held it in 15 quarters since.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.